Clinical trials
Completed Barrett Esophagus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
157 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 6 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 7 |
| 2006 | 5 |
| 2007 | 11 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 16 |
| 2011 | 10 |
| 2012 | 11 |
| 2013 | 8 |
| 2014 | 12 |
| 2015 | 10 |
| 2016 | 9 |
| 2017 | 9 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 6 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 157 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 27 |
| Massachusetts General Hospital | 8 |
| University of North Carolina, Chapel Hill | 6 |
| National Cancer Institute (NCI) | 5 |
| Case Comprehensive Cancer Center | 4 |
| Columbia University | 4 |
| Medtronic - MITG | 4 |
| Pentax Medical | 4 |
| Portsmouth Hospitals NHS Trust | 4 |
| University of Michigan | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barrett Esophagus | 157 |
| Gastroesophageal Reflux | 35 |
| Esophageal Neoplasms | 22 |
| Adenocarcinoma | 4 |
| Esophagitis, Peptic | 3 |
| Stomach Neoplasms | 3 |
| Deglutition Disorders | 2 |
| Eosinophilic Esophagitis | 2 |
| Obesity | 2 |
| Precancerous Conditions | 2 |
Trials
Showing 26 to 50 of 157. Each trial links to its page on Pharma Observatory.
57 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.